Covid-19: UK approves monoclonal antibody sotrovimab for over 12s at high risk. Mahase E. BMJ 2021;375:n2990.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Covid-19: UK approves monoclonal antibody sotrovimab for over 12s at high risk. BMJ 2021;375:n2990.
PMID: 34857518